Your session is about to expire
← Back to Search
Ketamine for Suicide Attempts
Study Summary
This trial is testing whether ketamine can help decrease suicidal ideation in young people who have attempted suicide.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been diagnosed with autism or are unable to speak.I am between 14 and 30 years old.I have high blood pressure or heart issues, or my EKG shows a QTcF of 450 msec or more.I do not have allergies or conditions that prevent me from using ketamine.I am an adolescent weighing more than 100 kg.I have an intellectual disability with an IQ below 70.I weigh more than 115 kg.I have used ketamine recreationally or therapeutically but not more than 480 mg in total.You have been diagnosed with schizophrenia or have a history of any type of mental illness that causes hallucinations or loss of touch with reality.You have been diagnosed with certain types of personality disorders, like borderline personality disorder.
- Group 1: Ketamine Treatment + CAMS Therapy
- Group 2: Saline Placebo Treatment + CAMS Therapy
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you list other research that has used Ketamine Hydrochloride?
"The first study using ketamine hydrochloride was completed in 2013 at Cedars Sinai Medical Center. Since then, a total of 844 clinical trials have been completed. Currently, 115 clinical trials are ongoing, with a significant number of these trials taking place in Cleveland, Ohio."
Has Ketamine Hydrochloride received formal backing from the FDA?
"There is some clinical evidence to support the safety of Ketamine Hydrochloride, and because this is a Phase 3 trial, it received a score of 3."
Will this test be conducted on individuals who are octogenarians?
"Eligibility for this particular study is limited to those aged 15-24. Out of the 301 total clinical trials, 74 are for patients under 18 years old and 209 are for patients over 65."
Do I meet the prerequisites to join this clinical trial?
"This study is open to 140 participants who are currently experiencing parasuicide and meet the following criteria: Subjects must be 15 to 24 years of age, Subjects must have been admitted to the hospital inpatient unit after a suicide attempt (any intentional, non-fatal self- injury regardless of medical lethality, if intent to die was indicated) and continued to express suicidal ideation. Also at time of screening clinician rated Scale for Suicidal Ideation (SSI) score should be ≥6., Subjects must have the ability to understand and the willingness to sign a written informed consent document."
What is the desired number of participants for this trial?
"That is correct. The clinical trial in question is still looking for patients, as seen on clinicaltrials.gov. The study was first posted on 6/27/2022 and was most recently updated on 8/1/2022. They are aiming to enroll 140 patients total at 2 different sites."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger